Photo Credit: South African Cricketers’ Association
The International Cricket Council (ICC) today confirmed that Zubayr Hamza will serve a suspension of nine months, commencing on the 22 March 2022, following his positive test for the prohibited substance Furosemide.
Andrew Breetzke, SACA CEO, commented; “from the outset, Zubayr co-operated with the ICC on providing full disclosure of medications that he had been taking, and the sequence of events leading up to the positive test. Through this process, we were able to determine how Furosemide came to be in his sample.
The ICC considered and accepted his submission, and we are pleased that Zubayr will be back playing cricket at the end of this year. SACA will continue to support Zubayr during the period of his suspension”.
Zubayr noted his relief that the matter had been concluded; “I wish to thank the ICC for the professional manner in which they managed this process. I have never intentionally taken a prohibited substance and I am relieved that the ICC determination confirms this fact. The past few months have been difficult for me on a personal and professional level, and I have learnt lessons that I will share with my fellow players.
I would like to thank Cricket South Africa and Western Province for their support during this time. I would also like to thank my attorney, Barend Kellerman, for his expertise in navigating this process, and SACA for their comprehensive support during what has been a difficult time for me.”
